Literature DB >> 35120079

Developmental Disruptions of the Human Stapes.

Thaís Gomes Abrahão Elias1, Felipe Santos2.   

Abstract

OBJECTIVE: To evaluate and classify developmental malformations of the human stapes.
METHODS: Twenty-five temporal bone specimens from 18 patients with congenital stapes malformations were identified in the Mass Eye and Ear temporal bone collection. Serial sections stained with hematoxylin and eosin were examined by light microscopy and the morphology of the stapes was compared to age-matched controls.
RESULTS: Each case of stapes malformation could be classified into one of four malformation types based on our current understanding of the embryologic origin of the subunits of the stapes and timing of development. Twenty-seven percent of stapes malformations had a Type I morphology characterized by a hypoplastic or absent inner footplate and hypoplastic to absent mesoderm footplate or oval window. The crura and capitulum may be absent, monopodal or dysmorphic. Eleven percent expressed a Type II malformation with dysmorphic or monopodal capitulum and crura and a fixed footplate. Twenty-seven percent were of Type III with a dysmorphic or monopodal capitulum and or crura. The footplate, and thereby oval window is present and without fixation. The most common malformation, Type IV, was isolated footplate fixation observed in 33% of cases.
CONCLUSIONS: Malformations of the human stapes follow consistent patterns of early or late disruptions of the stapes subunits of mesodermal and/or neural crest origin. While the molecular events, including temporal coordination, that lead to a normally formed stapes are not yet fully understood, the observed patterns of human stapes malformation can be consistently classified into one of four patterns of developmental disruption.
Copyright © 2022, Otology & Neurotology, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35120079      PMCID: PMC8982995          DOI: 10.1097/MAO.0000000000003490

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  14 in total

1.  Phylogeny and embryology of the facial nerve and related structures. Part II: Embryology.

Authors:  Robert Thayer Sataloff; Jesse C Selber
Journal:  Ear Nose Throat J       Date:  2003-10       Impact factor: 1.697

Review 2.  Developmental origin and fate of middle ear structures.

Authors:  Ulrike J Sienknecht
Journal:  Hear Res       Date:  2013-02-08       Impact factor: 3.208

3.  Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton.

Authors:  L J Brunet; J A McMahon; A P McMahon; R M Harland
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

4.  The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues.

Authors:  D M Noden
Journal:  Dev Biol       Date:  1983-03       Impact factor: 3.582

5.  Second branchial arch lineages of the middle ear of wild-type and Hoxa2 mutant mice.

Authors:  Stephen O'Gorman
Journal:  Dev Dyn       Date:  2005-09       Impact factor: 3.780

Review 6.  Function and expression pattern of nonsyndromic deafness genes.

Authors:  Nele Hilgert; Richard J H Smith; Guy Van Camp
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

7.  Surgical management of congenital conductive deafness.

Authors:  J B Farrior
Journal:  South Med J       Date:  1987-04       Impact factor: 0.954

8.  The origin of the stapes and relationship to the otic capsule and oval window.

Authors:  Hannah Thompson; Atsushi Ohazama; Paul T Sharpe; Abigail S Tucker
Journal:  Dev Dyn       Date:  2012-08-02       Impact factor: 3.780

9.  BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest.

Authors:  B Kanzler; R K Foreman; P A Labosky; M Mallo
Journal:  Development       Date:  2000-03       Impact factor: 6.868

10.  The triple origin of skull in higher vertebrates: a study in quail-chick chimeras.

Authors:  G F Couly; P M Coltey; N M Le Douarin
Journal:  Development       Date:  1993-02       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.